Clinical Profile of Cutaneous Adverse Effects of Epidermal Growth Factor Receptor Inhibitors: A Prospective Observational Study of 76 Cases

BACKGROUND: Epidermal growth factor receptor (EGFR) inhibitors are an extensively utilized class of chemotherapeutic agents which form an integral component of treatment in solid organ malignancies such as non-small-cell lung carcinoma, pancreatic carcinoma, colorectal carcinoma, and head and neck c...

Descripción completa

Detalles Bibliográficos
Autores principales: Saraswat, Neerja, Sood, Aradhana, Kumar, Dharmesh, Verma, Rajesh, Sushil, Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536076/
https://www.ncbi.nlm.nih.gov/pubmed/31149566
http://dx.doi.org/10.4103/idoj.IDOJ_325_18

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6536076/
https://www.ncbi.nlm.nih.gov/pubmed/31149566
http://dx.doi.org/10.4103/idoj.IDOJ_325_18

Ejemplares similares